N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells
- PMID: 427742
N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells
Abstract
Human colon carcinoma cell lines established in this laboratory were treated in vitro with N,N-dimethylformamide. This polar solvent caused morphological changes in the cells as well as alterations in their growth properties. Untreated cells had cloning efficiencies of up to 77% in soft agar; treatment with N,N-dimethylformamide resulted in a complete loss of clonogenicity in semisolid medium. Growth in the presence of the polar solvent also effected a marked reduction in the tumorigenicity of the cells. Ten of ten nude mice that received a s.c. inoculum of 1 X 10(6) untreated cells developed tumors histologically similar to colonic adenocarcinomas in 10 to 14 days, whereas nine of ten nude mice inoculated with 1 X 10(6) treated cells have shown no sign of tumor 3 to 6 months postinjection. Removal of the polar solvent from the culture medium was accompanied by the reappearance of tumorigenicity and the original cell culture characteristics. Therefore, it appears that N,N-dimethylformamide can reversibly effect the reversion of cultured human colon carcinoma cells to less malignant cell types.
Similar articles
-
N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.Cancer Res. 1977 Sep;37(9):3136-40. Cancer Res. 1977. PMID: 195720
-
Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line.Cancer Res. 1986 Mar;46(3):1297-305. Cancer Res. 1986. PMID: 3943098
-
Inhibition of the growth of human colon cancer xenografts by polar solvents.Cancer Res. 1982 Dec;42(12):5018-22. Cancer Res. 1982. PMID: 7139607
-
Heterogeneity of human colon carcinoma.Cancer Metastasis Rev. 1984;3(3):177-91. doi: 10.1007/BF00048384. Cancer Metastasis Rev. 1984. PMID: 6437669 Review.
-
Polar solvents: a novel class of antineoplastic agents.J Clin Oncol. 1984 Mar;2(3):227-41. doi: 10.1200/JCO.1984.2.3.227. J Clin Oncol. 1984. PMID: 6321692 Review.
Cited by
-
Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.Int J Gastrointest Cancer. 2005;36(2):77-87. doi: 10.1385/IJGC:36:2:77. Int J Gastrointest Cancer. 2005. PMID: 16648657
-
Epigenetic and genetic features of 24 colon cancer cell lines.Oncogenesis. 2013 Sep 16;2(9):e71. doi: 10.1038/oncsis.2013.35. Oncogenesis. 2013. PMID: 24042735 Free PMC article.
-
Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis.J Exp Clin Cancer Res. 2021 Jul 7;40(1):225. doi: 10.1186/s13046-021-02025-2. J Exp Clin Cancer Res. 2021. PMID: 34233735 Free PMC article.
-
The human lung adenocarcinoma cell line EKVX produces an infectious xenotropic murine leukemia virus.Viruses. 2011 Dec;3(12):2442-61. doi: 10.3390/v3122442. Epub 2011 Dec 19. Viruses. 2011. PMID: 22355448 Free PMC article.
-
Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.Invest New Drugs. 2003 Feb;21(1):33-45. doi: 10.1023/a:1022912208877. Invest New Drugs. 2003. PMID: 12795528
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials